Ezgi Ilan

Theranostics in Neuroendocrine Tumors: Somatostatin Receptor Imaging and Therapy

Ilan, Ezgi

2022

• Ladda ner fulltext (pdf) av Theranostics in Neuroendocrine Tumors: Somatostatin Receptor Imaging and Therapy

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Jahn, Ulrika; Ilan, Ezgi; Velikyan, Irina; Fröss-Baron, Katarzyna et al.

Ingår i EJNMMI Research, 2021

• DOI för Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT
• Ladda ner fulltext (pdf) av Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Lubberink, Mark et al.

Ingår i Cancers, 2021

• DOI för Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
• Ladda ner fulltext (pdf) av Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Ingår i Neuroendocrinology, s. 662-670, 2020

• DOI för ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Sundin, Anders et al.

Ingår i Journal of Nuclear Medicine, s. 217-221, 2020

• DOI för Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Jahn, Ulrika; Ilan, Ezgi; Velikyan, Irina; Fröss-Baron, Katarzyna et al.

Ingår i EJNMMI Research, 2021

• DOI för Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT
• Ladda ner fulltext (pdf) av Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Lubberink, Mark et al.

Ingår i Cancers, 2021

• DOI för Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms
• Ladda ner fulltext (pdf) av Peptide Receptor Radionuclide Therapy (PRRT) with ¹⁷⁷Lu-DOTATATE: Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Ingår i Neuroendocrinology, s. 662-670, 2020

• DOI för ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors

Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Sundin, Anders et al.

Ingår i Journal of Nuclear Medicine, s. 217-221, 2020

• DOI för Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE.

In vivo instability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Lubberink, Mark; Wilking, Helena; Öst, Amalia; Ilan, Ezgi et al.

Ingår i Journal of Nuclear Medicine, s. 1337-1340, 2020

• DOI för In vivo instability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

Lindström, Elin; Sundin, Anders; Trampal, Carlos; Lindsjö, Lars et al.

Ingår i Journal of Nuclear Medicine, s. 1152-1158, 2018

• DOI för Evaluation of penalized likelihood estimation reconstruction on a digital time-of-flight PET/CT scanner for 18F-FDG whole-body examinations

In-vivo stability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Wilking, H.; Ilan, Ezgi; Sandström, Mattias; Andersson, C. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för In-vivo stability of ¹⁷⁷Lu-DOTATATE during peptide receptor radionuclide therapy

Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Lubberink, Mark; Sandström, Mattias; Jahn, Ulrika et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors

Jahn, Ulrika; Ilan, Ezgi; Sandström, Mattias; Garske-Román, Ulrike et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

Parametric Net Influx Rate Images of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Ilan, Ezgi; Sandström, Mattias; Velikyan, Irina; Sundin, Anders et al.

Ingår i Journal of Nuclear Medicine, s. 744-749, 2017

• DOI för Parametric Net Influx Rate Images of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Low tracer availability of Ga-68-DOTATOC and Ga-68-DOTATATE in blood for patients with high SSTR density leads to non-linear correlation between SUV and K-i

Ilan, Ezgi; Sundin, Anders; Velikyan, Irina; Sandström, Mattias et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Gender-related differences in absorbed dose to risk organs in patients receiving Lu-177-Octreotate therapy

Sandström, Mattias; Ilan, Ezgi; Fröss-Baron, Katarzyna; Garske, Ulrike et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017

Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System

Hsu, David Fc; Ilan, Ezgi; Peterson, William T; Uribe, Jorge et al.

Ingår i Journal of Nuclear Medicine, s. 1511-1518, 2017

• DOI för Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System

Optimisation of penalized likelihood estimation reconstruction (Q.Clear) on a digital time-of-flight PET-CT scanner for four different PET tracers

Lindström, Elin; Lindsjö, Lars; Ilan, Ezgi; Sundin, Anders et al.

Ingår i Journal of Nuclear Medicine, 2017

Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System

Hsu, David; Ilan, Ezgi; Peterson, William; Uribe, Jorge et al.

Ingår i Journal of Nuclear Medicine, 2017

Performance comparison of three commercially available PET systems: SIGNA PET/MR, Discovery IQ and Discovery MI

Ilan, Ezgi; Deller, Timothy; Kjellberg, Fredric; Peterson, William et al.

Ingår i Journal of Nuclear Medicine, 2017

Is there a gender difference of absorbed dose to the risk organs in patients receiving ¹⁷⁷Lu-Octreotate therapy?

Sandström, Mattias; Ilan, Ezgi; Sundin, Anders; Lubberink, Mark

Ingår i Journal of Nuclear Medicine, 2017

Image quality measurements with ¹⁷⁷Lu on a GE Discovery 670 CZT

Sandström, Mattias; Ilan, Ezgi; Sundin, Anders; Lubberink, Mark

Ingår i Journal of Nuclear Medicine, 2017

Comparison of PET/CT and PET/MR-based Ga-68-DOTATOC standardized uptake values

Ilan, Ezgi; Sundin, Anders; Velikyan, Irina; Sandström, Mattias et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2016

Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

Ilan, Ezgi; Sandström, Mattias; Wassberg, Cecilia; Sundin, Anders et al.

Ingår i Journal of Nuclear Medicine, s. 177-182, 2015

• DOI för Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.

Sandström, Mattias; Ilan, Ezgi; Karlberg, Anna; Johansson, Silvia et al.

Ingår i EJNMMI Physics, 2015

• DOI för Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.
• Ladda ner fulltext (pdf) av Method dependence, observer variability and kidney volumes in radiation dosimetry of (177)Lu-DOTATATE therapy in patients with neuroendocrine tumours.

Validation of parametric net influx rate images of Ga-68-DOTATOC and Ga-68-DOTATATE

Ilan, Ezgi; Sandström, Mattias; Velikyan, Irina; Sundin, Anders et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2015

Comparison of ⁶⁸Ga-DOTATATE and ¹⁷⁷Lu-DOTATATE kinetics in neuroendocrine tumors

Ilan, Ezgi; Velikyan, Irina; Sandström, Mattias; Andersson, Camilla et al.

Theranostics in Neuroendocrine Tumors: Somatostatin Receptor Imaging and Therapy

Ilan, Ezgi

2022

• Ladda ner fulltext (pdf) av Theranostics in Neuroendocrine Tumors: Somatostatin Receptor Imaging and Therapy